Please enter the email address you used to register, then we will send you a link to choose a new password
NKGN: 88% | NKGen Biotech Will Present New Biomarker Data On SNK01 In Alzheimer's Disease During A Poster Presentation At The Upcoming Alzheimer's Association International Conference From July 28 – August 1
AGEN: -63% | Agenus shares are trading lower after the company announced the FDA discouraged an accelerated approval pathway at the end-of-Phase 2 meeting.
BYND: -25% | Beyond Meat shares are trading lower following a report suggesting the company's liquidity has weakened and it is engaging bondholders for debt discussions.
Posted In: AGEN BYND NKGN